ArticlePharmacology research & perspectives2025

Assessment of Potential Drug-Drug Interactions for Novel Oral Melanocortin-1 Receptor Agonist Dersimelagon.

Akihito Ogasawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.